# Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004

> **NCT00426101** · PHASE3 · COMPLETED · sponsor: **Karolinska University Hospital** · enrollment: 368 (actual)

## Conditions studied

- Hemophagocytic Lymphohistiocytosis

## Interventions

- **DRUG:** Dexamethasone
- **DRUG:** Etoposide
- **DRUG:** Cyclosporin
- **PROCEDURE:** Intrathecal therapy
- **PROCEDURE:** Stem cell transplant

## Key facts

- **NCT ID:** NCT00426101
- **Lead sponsor:** Karolinska University Hospital
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2004-01
- **Primary completion:** 2011-12
- **Final completion:** 2017-12
- **Target enrollment:** 368 (ACTUAL)
- **Last updated:** 2018-07-05

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00426101

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00426101, "Treatment Protocol for Hemophagocytic Lymphohistiocytosis 2004". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT00426101. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*